ARCHIVES

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

ICCCR Loses Support Of French, DeVita Resigns As President, Fischinger To Take Over

July 17, 1992

Komen Board Approved Defunding Planned Parenthood, Says Karen Handel

February 10, 2012

NCI names Porter Novelli executive as director for strategic dissemination.

August 1, 2003

News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters

May 20, 1994

First Lady Helps Dedicate New MDA Facilities

October 15, 1976

Karmanos Cancer Center Wins $4.6M From U.S. Army.

September 5, 2008